These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3476168)

  • 21. In vitro enhancement of immunoglobulin gene expression in chronic lymphocytic leukemia.
    Cossman J; Neckers LM; Braziel RM; Trepel JB; Korsmeyer SJ; Bakhshi A
    J Clin Invest; 1984 Feb; 73(2):587-92. PubMed ID: 6607934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of tartrate-resistant acid phosphatase in B-CLL treated with phorbol ester or phorbol ester plus calcium ionophore.
    Drexler HG; Brenner MK; Gignac SM; Hoffbrand AV
    Eur J Haematol; 1988 Sep; 41(3):250-7. PubMed ID: 3141210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prolymphocytic and hairy cell leukemias as special forms of chronic lymphatic leukemia].
    Abbrederis K; Michlmayr G; Schmalzl F
    Acta Med Austriaca; 1979; 6(5):226-8. PubMed ID: 299012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
    Nelson BP; Variakojis D; Peterson LC
    Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of chronic lymphocytic leukemia from other "well to intermediate differentiated" lymphoproliferative disorders by the mouse rosette assay.
    Hicks MJ; Grogan TM; Fielder K; Spier CM
    Diagn Immunol; 1986; 4(1):31-6. PubMed ID: 3456864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro induction of some features of hairy cell leukemia in chronic lymphocytic leukemia and immunocytoma cells.
    Ziegler-Heitbrock HW; Dörken B; Munker R; Riethmüller G; Thierfelder S; Thiel E
    Blut; 1985 Jan; 50(1):29-31. PubMed ID: 3967098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Question of differential diagnosis in a case of chronic B-cell lymphopathy].
    Moccia F; Casti P; Morra L
    Clin Ter; 1993 May; 142(5):421-31. PubMed ID: 8339525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic lymphoid leukemias: recent advances in biology and therapy.
    Foon KA
    Stem Cells; 1995 Jan; 13(1):1-21. PubMed ID: 7719244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
    Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
    J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of membrane marker phenotypes in hairy-cell leukemia and phorbol-ester induced B-cll cells using monoclonal antibodies.
    Herrmann F; Dörken B; Ludwig WD; Schwarting R
    Leuk Res; 1985; 9(5):529-36. PubMed ID: 2409407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
    Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
    Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
    Guy K; Meehan RR; Dewar AE; Larhammar D
    Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Induced differentiation of subpopulations of leukemic blood cells in patients with chronic B-cell lympholeukemia].
    Zlobina EN; Baryshnikov AIu
    Biull Eksp Biol Med; 1987 Mar; 103(3):340-2. PubMed ID: 3548840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
    Stöckbauer P; Malasková V; Soucek J; Chudomel V
    Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic action of calcium ionophore A23187 and phorbol ester TPA on B-chronic lymphocytic leukemia cells.
    Drexler HG; Brenner MK; Coustan-Smith E; Wickremasinghe RG; Hoffbrand AV
    Blood; 1987 Nov; 70(5):1536-42. PubMed ID: 3117134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
    al-Katib A; Wang CY; McKenzie S; Clarkson BD; Koziner B
    Am J Hematol; 1992 Aug; 40(4):264-9. PubMed ID: 1354412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
    Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
    J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD; Srivastava A; Srivastava BI
    Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.